Robotic tumor-specific mesorectal excison of rectal cancer: Short-term outcome of a pilot randomized trial

S. H. Baik, Y. T. Ko, C. M. Kang, W. J. Lee, N. K. Kim, S. K. Sohn, H. S. Chi, C. H. Cho

Research output: Contribution to journalArticle

201 Citations (Scopus)

Abstract

Background: Laparoscopic colorectal resection has become popular. The recently developed da Vinci Surgical System promises to facilitate endoscopic surgery and overcome its disadvantages. This study therefore aimed to compare the short-term results between robotic tumor-specific mesorectal excision (R-TSME) using the da Vinci Surgical System and conventional laparoscopic tumor-specific mesorectal excision (L-TSME) in rectal cancer patients. Methods: Between April 2006 and February 2007, 36 patients were randomly assigned to receive R-TSME or L-TSME. During the study, 18 patients underwent robotic low anterior resection using the da Vinci Surgical System, and 18 patients had conventional laparoscopic low anterior resection. Patient characteristics, perioperative clinical results, complications, and pathologic details were compared between the two groups. Results: The patient characteristics were not significantly different between the two groups. The mean operating time, hemoglobin change, and conversion rate were not significantly different between the groups. Complications were treated conservatively and did not require surgical intervention in the R-TSME group. The average length of stay was 6.9 ± 1.3 days in the R-TSME group and 8.7 ± 1.3 days in the L-TSME group (p < 0.001). The specimen quality of the R-TSME group was acceptable. Conclusion: Tumor-specific mesorectal excision was performed safely and effectively using the da Vinci Surgical System and the perioperative outcomes were acceptable.

Original languageEnglish
Pages (from-to)1601-1608
Number of pages8
JournalSurgical Endoscopy and Other Interventional Techniques
Volume22
Issue number7
DOIs
Publication statusPublished - 2008 Jul 1

Fingerprint

Robotics
Rectal Neoplasms
Neoplasms
Length of Stay
Hemoglobins

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

@article{b5e5cf8fd4f14989a71200824906b16b,
title = "Robotic tumor-specific mesorectal excison of rectal cancer: Short-term outcome of a pilot randomized trial",
abstract = "Background: Laparoscopic colorectal resection has become popular. The recently developed da Vinci Surgical System promises to facilitate endoscopic surgery and overcome its disadvantages. This study therefore aimed to compare the short-term results between robotic tumor-specific mesorectal excision (R-TSME) using the da Vinci Surgical System and conventional laparoscopic tumor-specific mesorectal excision (L-TSME) in rectal cancer patients. Methods: Between April 2006 and February 2007, 36 patients were randomly assigned to receive R-TSME or L-TSME. During the study, 18 patients underwent robotic low anterior resection using the da Vinci Surgical System, and 18 patients had conventional laparoscopic low anterior resection. Patient characteristics, perioperative clinical results, complications, and pathologic details were compared between the two groups. Results: The patient characteristics were not significantly different between the two groups. The mean operating time, hemoglobin change, and conversion rate were not significantly different between the groups. Complications were treated conservatively and did not require surgical intervention in the R-TSME group. The average length of stay was 6.9 ± 1.3 days in the R-TSME group and 8.7 ± 1.3 days in the L-TSME group (p < 0.001). The specimen quality of the R-TSME group was acceptable. Conclusion: Tumor-specific mesorectal excision was performed safely and effectively using the da Vinci Surgical System and the perioperative outcomes were acceptable.",
author = "Baik, {S. H.} and Ko, {Y. T.} and Kang, {C. M.} and Lee, {W. J.} and Kim, {N. K.} and Sohn, {S. K.} and Chi, {H. S.} and Cho, {C. H.}",
year = "2008",
month = "7",
day = "1",
doi = "10.1007/s00464-008-9752-z",
language = "English",
volume = "22",
pages = "1601--1608",
journal = "Surgical Endoscopy",
issn = "0930-2794",
publisher = "Springer New York",
number = "7",

}

Robotic tumor-specific mesorectal excison of rectal cancer : Short-term outcome of a pilot randomized trial. / Baik, S. H.; Ko, Y. T.; Kang, C. M.; Lee, W. J.; Kim, N. K.; Sohn, S. K.; Chi, H. S.; Cho, C. H.

In: Surgical Endoscopy and Other Interventional Techniques, Vol. 22, No. 7, 01.07.2008, p. 1601-1608.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Robotic tumor-specific mesorectal excison of rectal cancer

T2 - Short-term outcome of a pilot randomized trial

AU - Baik, S. H.

AU - Ko, Y. T.

AU - Kang, C. M.

AU - Lee, W. J.

AU - Kim, N. K.

AU - Sohn, S. K.

AU - Chi, H. S.

AU - Cho, C. H.

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Background: Laparoscopic colorectal resection has become popular. The recently developed da Vinci Surgical System promises to facilitate endoscopic surgery and overcome its disadvantages. This study therefore aimed to compare the short-term results between robotic tumor-specific mesorectal excision (R-TSME) using the da Vinci Surgical System and conventional laparoscopic tumor-specific mesorectal excision (L-TSME) in rectal cancer patients. Methods: Between April 2006 and February 2007, 36 patients were randomly assigned to receive R-TSME or L-TSME. During the study, 18 patients underwent robotic low anterior resection using the da Vinci Surgical System, and 18 patients had conventional laparoscopic low anterior resection. Patient characteristics, perioperative clinical results, complications, and pathologic details were compared between the two groups. Results: The patient characteristics were not significantly different between the two groups. The mean operating time, hemoglobin change, and conversion rate were not significantly different between the groups. Complications were treated conservatively and did not require surgical intervention in the R-TSME group. The average length of stay was 6.9 ± 1.3 days in the R-TSME group and 8.7 ± 1.3 days in the L-TSME group (p < 0.001). The specimen quality of the R-TSME group was acceptable. Conclusion: Tumor-specific mesorectal excision was performed safely and effectively using the da Vinci Surgical System and the perioperative outcomes were acceptable.

AB - Background: Laparoscopic colorectal resection has become popular. The recently developed da Vinci Surgical System promises to facilitate endoscopic surgery and overcome its disadvantages. This study therefore aimed to compare the short-term results between robotic tumor-specific mesorectal excision (R-TSME) using the da Vinci Surgical System and conventional laparoscopic tumor-specific mesorectal excision (L-TSME) in rectal cancer patients. Methods: Between April 2006 and February 2007, 36 patients were randomly assigned to receive R-TSME or L-TSME. During the study, 18 patients underwent robotic low anterior resection using the da Vinci Surgical System, and 18 patients had conventional laparoscopic low anterior resection. Patient characteristics, perioperative clinical results, complications, and pathologic details were compared between the two groups. Results: The patient characteristics were not significantly different between the two groups. The mean operating time, hemoglobin change, and conversion rate were not significantly different between the groups. Complications were treated conservatively and did not require surgical intervention in the R-TSME group. The average length of stay was 6.9 ± 1.3 days in the R-TSME group and 8.7 ± 1.3 days in the L-TSME group (p < 0.001). The specimen quality of the R-TSME group was acceptable. Conclusion: Tumor-specific mesorectal excision was performed safely and effectively using the da Vinci Surgical System and the perioperative outcomes were acceptable.

UR - http://www.scopus.com/inward/record.url?scp=51749125563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51749125563&partnerID=8YFLogxK

U2 - 10.1007/s00464-008-9752-z

DO - 10.1007/s00464-008-9752-z

M3 - Article

C2 - 18270772

AN - SCOPUS:51749125563

VL - 22

SP - 1601

EP - 1608

JO - Surgical Endoscopy

JF - Surgical Endoscopy

SN - 0930-2794

IS - 7

ER -